AstraZeneca plc (LON:AZN)’s share price traded up 1.4% during trading on Tuesday . The company traded as high as GBX 4,783.50 ($64.49) and last traded at GBX 4,774 ($64.37). 2,122,340 shares changed hands during mid-day trading, a decline of 7% from the average session volume of 2,293,550 shares. The stock had previously closed at GBX 4,710 ($63.50).

A number of equities analysts recently commented on the company. Berenberg Bank set a GBX 5,800 ($78.20) price objective on AstraZeneca plc and gave the stock a “buy” rating in a report on Tuesday. Jefferies Group LLC set a GBX 4,900 ($66.06) price objective on AstraZeneca plc and gave the stock a “neutral” rating in a report on Monday. Liberum Capital downgraded AstraZeneca plc from a “buy” rating to a “hold” rating and increased their price objective for the stock from GBX 4,800 ($64.72) to GBX 5,000 ($67.41) in a report on Thursday, September 14th. J P Morgan Chase & Co restated a “neutral” rating and issued a GBX 4,500 ($60.67) price objective on shares of AstraZeneca plc in a report on Thursday, September 14th. Finally, Barclays PLC set a GBX 6,300 ($84.94) price objective on AstraZeneca plc and gave the stock a “buy” rating in a report on Wednesday, September 13th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and nine have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of GBX 5,041.09 ($67.97).

The stock’s market capitalization is GBX 60.44 billion. The company has a 50-day moving average of GBX 4,574.46 and a 200 day moving average of GBX 4,884.61.

The company also recently disclosed a dividend, which was paid on Monday, September 11th. Shareholders of record on Thursday, August 10th were issued a GBX 68.90 ($0.93) dividend. This represents a yield of 1.35%. The ex-dividend date of this dividend was Thursday, August 10th.

In other news, insider Nazneen Rahman acquired 39 shares of the firm’s stock in a transaction on Thursday, July 27th. The shares were purchased at an average cost of GBX 4,370 ($58.92) per share, with a total value of £1,704.30 ($2,297.83).

COPYRIGHT VIOLATION WARNING: “AstraZeneca plc (AZN) Trading 1.4% Higher” was posted by Daily Political and is the property of of Daily Political. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/09/19/astrazeneca-plc-azn-trading-1-4-higher.html.

AstraZeneca plc Company Profile

AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience.

Receive News & Ratings for AstraZeneca plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca plc and related companies with MarketBeat.com's FREE daily email newsletter.